Literature DB >> 25332589

Hb Knossos: HBB:c.82G>T Associated with HBB:c.315+1G>A Beta Zero Mutation Causes Thalassemia Intermedia.

Hengameh Nasouhipur1, Ali Banihashemi2, Reza Youssefi Kamangar2, Haleh Akhavan-Niaki3.   

Abstract

β-thalassemia is the most common single gene disorder worldwide and in Iran. In the present study we report for the first time a rare variant of hemoglobin HBB:c.82G>T; Codon 27 GCC→TCC (Ala→Ser), Hb Knossos, using sequencing and reverse dot blot hybridization, in members of a family from North Iran. The family has a 16 years-old compound heterozygous thalassemia intermedia male child presenting this variant together with HBB:c.315+1G>A (IVSII-I) mutation. The father, heterozygous for Hb Knossos, showed borderline hematological indices. To our knowledge, this is the first report of Hb Knossos in trans with the β(O) IVSII-I allele leading to thalassemia intermedia. Our data also highlight the necessity of deep molecular characterization of subjects presenting normal HbA2 level associated with abnormal or borderline red cell indices.

Entities:  

Keywords:  Hb Knossos; Iran; Thalassemia intermedia

Year:  2014        PMID: 25332589      PMCID: PMC4192188          DOI: 10.1007/s12288-014-0343-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  14 in total

1.  A comprehensive molecular characterization of beta thalassemia in a highly heterogeneous population.

Authors:  Haleh Akhavan-Niaki; Poupak Derakhshandeh-Peykar; Ali Banihashemi; Amrollah Mostafazadeh; Beheshteh Asghari; Mohammad-Reza Ahmadifard; Mandana Azizi; Ali Youssefi; Maryam Mitra Elmi
Journal:  Blood Cells Mol Dis       Date:  2011-04-13       Impact factor: 3.039

2.  Beta-thalassemia intermedia in two Turkish families is caused by the interaction of Hb Knossos [beta 27(B9)Ala----Ser] and of Hb City of Hope [beta 69(E13)Gly----ser] with beta (0)-thalassemia.

Authors:  A Kutlar; F Kutlar; M Aksoy; A Gurgey; C Altay; J B Wilson; J C Diaz-Chico; H Hu; T H Huisman
Journal:  Hemoglobin       Date:  1989       Impact factor: 0.849

3.  Homozygous hemoglobin Knossos (alpha 2 beta 227(B9) Ala----Ser): a new variety of beta (+)-thalassemia intermedia associated with delta (0)-thalassemia.

Authors:  F Baklouti; E Dorléac; L Morlé; P Laselve; D Peyramond; M Aubry; J Godet; J Delaunay
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

4.  Abnormal processing of beta Knossos RNA.

Authors:  S H Orkin; S E Antonarakis; D Loukopoulos
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

5.  'Silent' beta-thalassaemia caused by a 'silent' beta-chain mutant: the pathogenesis of a syndrome of thalassaemia intermedia.

Authors:  P Fessas; D Loukopoulos; A Loutradi-Anagnostou; G Komis
Journal:  Br J Haematol       Date:  1982-08       Impact factor: 6.998

6.  The beta-thalassemia mutation spectrum in the Iranian population.

Authors:  H Najmabadi; R Karimi-Nejad; S Sahebjam; F Pourfarzad; S Teimourian; F Sahebjam; N Amirizadeh; M H Karimi-Nejad
Journal:  Hemoglobin       Date:  2001-08       Impact factor: 0.849

7.  Beta-thalassemia intermedia in Turkey.

Authors:  C Altay; A Gürgey
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

8.  Combination of Hb Knossos [Cod 27 (G-T)] and IVSII-745 (C-G) in a Turkish patient with beta-thalassemia major.

Authors:  Ibrahim Keser; Esra Manguoglu; Ozlem Kayisli; Akif Yesilipek; Guven Luleci
Journal:  Genet Test       Date:  2007

9.  δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients.

Authors:  Chaima Abdelhafidh Sahli; Amina Bibi; Faida Ouali; Hajer Siala; Sondess Hadj Fredj; Rym Othmani; Fekria Ouenniche; Mondher Cheour; Zohra Fitouri; Saida Ben Becher; Taieb Messaoud
Journal:  Clin Chem Lab Med       Date:  2012-10-01       Impact factor: 3.694

10.  The Spectrum of beta-Thalassemia Mutations in the Arab Populations.

Authors:  Laila Zahed
Journal:  J Biomed Biotechnol       Date:  2001
View more
  1 in total

1.  Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.

Authors:  Faten Moassas; Mohamad Sayah Nweder; Hossam Murad
Journal:  BMC Pediatr       Date:  2019-02-18       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.